VIDA provides automated software and analysis services to aid in the early detection, evaluation, and treatment planning of lung diseases, including lung cancer, emphysema, airway obstructive diseases, and asthma.
Our mission is to transform pulmonary care through intelligence. Powered by a unique combination of AI and quality-controlled image analysis services, VIDA’s solution aims to provide greater precision and personalization across a range of lung diseases including cancer, emphysema, airway obstructive diseases, asthma and interstitial lung disease. Our analysis is available for clinical use in the USA, EU, Canada and Australia.
Like a fingerprint, each lung is unique. LungPrint® is a fully-automated AI-powered analysis of a chest CT scan, providing quantified lung physiology and functional tissue. It provides validated quantitative CT information along with novel airway visualizations to increase the efficiency, quality, and precision in reporting lung CT abnormalities.
"LungPrint will empower radiologists to provide a richer set of quantitative CT lung information with a state-of-the-art CT report for the referring physician. The new airway display is remarkable."
"VIDA's solution is more than necessary for me to treat a pulmonary valve patient. With VIDA, it is much safer for the patient as well."
"VIDA saves me close to $1,200 per procedure and at over 150 procedures a year, upwards of over $150k in annual savings."
"The interventional pulmonology field is advancing with the emergence of both novel therapies for patients with emphysema and the essential analytics to accurately match the patient to the therapy for greater response."
VIDA in the News
VIDA in the Journals
2500 Crosspark Rd.
W250 BioVentures Center
Coralville, IA 52241
7505 Metro Blvd
Edina, MN 55439
Silicon Valley Office
Palo Alto, CA